Kubayi would also have had to answer several questions from DA MP Gordon Mackay on the recent suspension of her department's director-general for policy, planning and clean energy, Ompi Aphane ... up of the strategic fuel stock sale …
Valeant Pharmaceuticals International, Inc. (VRX) recently announced that the company has entered into a definitive agreement to acquire all of the outstanding common stock of Obagi Medical Products, Inc. (OMPI) for $19.75 per share …
It comprises two operational divisions dedicated to serve the pharmaceutical industry: Pharmaceutical Systems with …
Collectively, the two own 0.7 percent of outstanding common stock, according to Thomson Reuters data ... its intention to replace the entire board of Obagi Medical Products Inc OMPI.O. Soon after that Obagi said it would be sold to Valeant …
Shares of Obagi Medical Products, Inc. (NASDAQ:OMPI) continue to climb steadily and traded as high ... report with a …
Vancouver, BC, June 30, 2012 - (ACN Newswire) - Mid-Day Healthcare Stocks Review: Obagi Medical Products, Inc. (NASDAQ:OMPI - News) Shares up and rising $14.94 Up 0.66 (+4.61%) on unusual volume after buy-out rumors …
Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic ... 1.5 million shares of …
Valeant Pharmaceuticals’ (VRX) proposed acquisition of Obagi Medical Products, Inc. (OMPI) received a boost with Merz Pharma ... In Dec 2012, Valeant acquired the entire outstanding common stock of Medicis Pharmaceutical Corporation …
Vancouver, BC, May 15, 2012 - (ACN Newswire) - Shares of Obagi Medical Products (NASDAQ:OMPI - News) rose 4.69% on Monday to $ ... andestimated a U.S. license for ~$250M with +$2-3 upside to the stock," wrote Rivkind. " We think …